The Scotts Miracle-Gro Company is upgraded to a soft Buy as profitability and cash flow have improved despite revenue declines. SMG's Hawthorne segment, hurt by cannabis oversupply, is being wound down, boosting overall profitability and reducing exposure to volatile markets. U.S. Consumer segment growth, debt reduction, and cost controls have driven net profit from a $380.1M loss in 2023 to a $145.2M gain in 2025.
Here is how Scotts Miracle-Gro (SMG) and United Natural Foods (UNFI) have performed compared to their sector so far this year.
Scotts (SMG) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
SMG posts a narrower fiscal Q4 loss but misses estimates; unveils FY26 outlook with modest growth and improved profitability targets.
The Scotts Miracle-Gro Company ( SMG ) Q4 2025 Earnings Call November 5, 2025 9:00 AM EST Company Participants Brad Chelton - Vice President of Treasury, Tax & Investor Relations James Hagedorn - CEO & Chairman of the Board Mark Scheiwer - Executive VP, CFO & Chief Accounting Officer and Treasurer Nate Baxter - President & Chief Operating Officer John Sass Conference Call Participants Jon Andersen - William Blair & Company L.L.C., Research Division W.
Although the revenue and EPS for Scotts (SMG) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
I am upgrading SMG to a 'buy' as its turnaround gains momentum, with improving margins, healthy retail inventories, and market share gains. Core lawn and garden business shows resilience, with positive consumer sales, effective marketing, and e-commerce growth offsetting Hawthorne's weakness. Debt reduction and margin expansion are on track, supporting a secure 4.25% dividend and potential for share buybacks as leverage falls.
The company created a line of products for legal cannabis growers, a bet that for a time looked like genius.
SMG tops Q3 earnings estimates on stronger margins, but sales fall short amid a sharp Hawthorne segment decline.
The Scotts Miracle-Gro Company (NYSE:SMG ) Q3 2025 Earnings Conference Call July 30, 2025 9:00 AM ET Company Participants Brad Chelton - Corporate Participant James S. Hagedorn - CEO & Chairman of the Board John Sass - Corporate Participant Mark J.
Although the revenue and EPS for Scotts (SMG) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.